These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 5006252

  • 1. Immunohistochemistry of glomerulonephritis.
    Berger J, Yaneva H, Hinglais N.
    Adv Nephrol Necker Hosp; 1971; 1():11-30. PubMed ID: 5006252
    [No Abstract] [Full Text] [Related]

  • 2. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
    Kim Y, Vernier RL, Fish AJ, Michael AF.
    Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
    [Abstract] [Full Text] [Related]

  • 3. [Early components of complement in glomerular depositions].
    Berger J.
    Pathol Biol (Paris); 1975 Jun; 23(6):484. PubMed ID: 1105351
    [No Abstract] [Full Text] [Related]

  • 4. Interpretation of immunofluorescent patterns in renal diseases.
    Valenzuela R, Deodhar SD.
    Pathobiol Annu; 1980 Jun; 10():183-221. PubMed ID: 7003493
    [No Abstract] [Full Text] [Related]

  • 5. New insights into the pathogenesis of glomerulonephritis afforded by the study of renal allografts.
    Hamburger J, Berger J, Hinglais N, Descamps B.
    Clin Nephrol; 1973 Jun; 1(1):3-7. PubMed ID: 4588242
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evidence for activation of the alternate pathway in glomerulonephritis.
    Michael AF, McLean RH.
    Adv Nephrol Necker Hosp; 1974 Jun; 4():49-66. PubMed ID: 4219999
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of immunoglobulin G anti-glomerular basement membrane antibodies eluted from kidneys of patients with glomerulonephritis. II. IgG subtypes and in vitro complement fixation.
    McPhaul JJ, Dixon FJ.
    J Immunol; 1971 Sep; 107(3):678-84. PubMed ID: 4999091
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
    Strife CF, McEnery PT, McAdams AJ, West CD.
    Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Complement deposition in the kidney.
    Berger J.
    Adv Nephrol Necker Hosp; 1974 Feb; 4():37-48. PubMed ID: 4219998
    [No Abstract] [Full Text] [Related]

  • 19. Antibasement membrane disease. I. The glomerular lesions of Goodpasture's disease and experimental disease in sheep.
    Germuth FG, Choi IJ, Taylor JJ, Rodriguez E.
    Johns Hopkins Med J; 1972 Nov; 131(5):367-84. PubMed ID: 5087173
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.